Innovation1 Biotech IncOTCQB:IVBT
- LAST PRICE0.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | IVBT |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Innovation1 Biotech Inc | 4.0M | -0.1x | --- |
CLSTV Corp | 3.8M | 0.0x | --- |
HealthWarehouse.com Inc | 8.6M | -7.3x | --- |
Bimi International Medical Inc | 6.8M | 0.0x | --- |
SunLink Health Systems Inc | 6.0M | -1.1x | --- |
ScripsAmerica Inc | 140.0 | 0.0x | --- |
Company Information
Innovation1 Biotech, Inc. is developing products using five preclinical prodrugs, all fully synthetic, which include a mushroom-derived psychedelic molecule for treatment post-traumatic stress disorder and depression, a cannabinoid and tree bark derived psychedelic for treatment of addiction and three additional cannabinoid prodrugs addressing clinical indications of refractory epilepsy, burn wounds and uveitis. The Company also owns a patented nutraceutical complex, which is designed and formulated to contribute and help in maintaining normal energy metabolism, improve mood and reduce fatigue for those suffering from fibromyalgia and chronic fatigue syndrome. The Company markets its products under the trademark Gridiron BioNutrients and Gridiron MVP, including GridironMVP Alkaline Nutrition with Probiotics, GridironMVP Concentrate, Gridiron CBD Premium Hemp Tinctures, Gridiron CBD Gummies and Gridiron CBD Salve. It markets its products through its Website www.gridironmvp.com.
Contact Information
- Headquarters
- 179 RTE 46W, SUITE 15 #147ROCKAWAY, NJ, United States 07866
- Phone
- 929-459-4966
- Fax
- ---
Executives
- Chief Executive Officer, Director
- Jeffrey Kraws
- Director
- Charles Allen
- Director
- Jason Frankovich
- Director
- Shahin Gharakhanian
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 5.00 |
EPS | $-2.68 |
Book Value | $0.14 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
